Aagami, Inc. | Strategic Consulting, Technology Licensing, Business Research & Market Intelligence, Business Development support

Our Services

Your Needs We Serve

M&A/Divestiture

Support in M&A and Divestment of Assets, Techs, IP, Companies etc.

Funding/Investment

Advisory and BD support for Funding and Venture Capital needs

Partnership/Co-development

Various types of development partnering support

Licensing/Commercialization

Support all stages of licensing (Product/IP/Tech) from Pre-Clinical to on the Market

Latest News

New Client Win: Aagami Appointed to Secure Strategic Partnerships, Licensing, and Funding for Phase 3-Ready Cardiovascular Asset Targeting Atrial Fibrillation

CHICAGO, IL — July 2, 2026 — Aagami, Inc., a premier global life sciences consulting firm, today announced it has been appointed by an innova...

New Client Win: Aagami Appointed by Innovative Biopharmaceutical Company to Secure Strategic Partnering and Global Licensing for Advanced Oncology and Rare Disease Pipelines

CHICAGO, IL — July 1, 2026 — Aagami, Inc., a premier global life sciences consulting firm, is proud to announce a new client win. An innovati...

Aagami Appointed to Secure Exclusive Regional Partners in Japan and South Korea for Advanced Neurosurgical MRI and Robotics

CHICAGO, IL — June 19, 2026 — Marking its second major East Asian partnering mandate in the medical technology sector this week, Aagami, Inc....

“ We are pleased by Aagami Team’s good work, in a professional and gracious manner. We would be delighted to recommend your services to others ”

CEO of a Oregon, US based Biotech

“ The virtues of working with Aagami include the team’s attentiveness to us and to the potential partners, persistence in follow-up and most of all, integrity”

Founder and CEO of a California based Biopharma

“ While we think we understand business, terminology and customs change from Country to Country. Without having an intimate knowledge of these differences, a gap if you will, it is difficult if not impossible to transact equitable arrangements. Aagami is the bridge that crosses this gap. Importantly it does so openly and honestly”

Founder and CEO of a publicly Listed Australian Technology Development Company

“ We have worked with many Consultants in US and Canada, however, in our experience, none of them are worthy of even standing in Aagami’s Shadow. We are blessed to have Aagami on our side. ”

CEO of a Specialty Chemicals company based in North America

The service provided was excellent. Everything was handled in a thorough & professional manner. A large number of opportunities were identified, facilitated and progressed to a conclusion.

VP of a UK based Pharma

Aagami Team are Very Professional and Prompt in communication

Founder of a US Labware Consumables Company

Aagami laid out a pretty clear process and stuck to it, which is not often the case when engaging advisors for BD assignments. Also Aagami were very well connected. We had the opportunity to sign two deals via Aagami, which we had not anticipated.

Stephen Yoder, CEO, Pieris Pharmaceuticals

Honest and transparent communication. Dedicated approach, hard working

Martin Welschof, CEO, Opsona Therapeutics

"We were very satisfied with the outcome, and the final report, along with much additional data from subsequent trials conducted by our current licensees, now forms a part of our extensive Drug Master File at the FDA."

Edward T. Maggio, PhD, CEO of Aegis Therapeutics (Currently Consultant to Neurelis, who purchased Aegis at the end of November 2018)

"Professional and disciplined approach to execution of the project."

Sr. VP of a NY based Pharma (Now a part of Endo)

Business Development support in regions
where you are unable to reach out due to bandwidth

Market Intelligence and IP Research
using new age tools

Deep Experience of overcoming
business and socio-cultural differences among various countries/regions

Why Aagami

Value Proposition

130+

235+

30+

250+

Our Services

M&A/Divestiture

Funding/Investment

Partnership/Co-development

Licensing/Commercialization

Success Stories

Help us understand your needs

Latest News

New Client Win: Aagami Appointed to Secure Strategic Partnerships, Licensing, and Funding for Phase 3-Ready Cardiovascular Asset Targeting Atrial Fibrillation

New Client Win: Aagami Appointed by Innovative Biopharmaceutical Company to Secure Strategic Partnering and Global Licensing for Advanced Oncology and Rare Disease Pipelines

Aagami Appointed to Secure Exclusive Regional Partners in Japan and South Korea for Advanced Neurosurgical MRI and Robotics

Testimonials

“ We are pleased by Aagami Team’s good work, in a professional and gracious manner. We would be delighted to recommend your services to others ”

“ The virtues of working with Aagami include the team’s attentiveness to us and to the potential partners, persistence in follow-up and most of all, integrity”

“ We have worked with many Consultants in US and Canada, however, in our experience, none of them are worthy of even standing in Aagami’s Shadow. We are blessed to have Aagami on our side. ”

The service provided was excellent. Everything was handled in a thorough & professional manner. A large number of opportunities were identified, facilitated and progressed to a conclusion.

Aagami Team are Very Professional and Prompt in communication

Aagami laid out a pretty clear process and stuck to it, which is not often the case when engaging advisors for BD assignments. Also Aagami were very well connected. We had the opportunity to sign two deals via Aagami, which we had not anticipated.

Honest and transparent communication. Dedicated approach, hard working

"We were very satisfied with the outcome, and the final report, along with much additional data from subsequent trials conducted by our current licensees, now forms a part of our extensive Drug Master File at the FDA."

"Professional and disciplined approach to execution of the project."

Social Media

Contact Us

Locate Us

Subscribe Us

Business Development support in regionswhere you are unable to reach out due to bandwidth

Market Intelligence and IP Research using new age tools

Deep Experience of overcoming business and socio-cultural differences among various countries/regions

Why Aagami

Value Proposition

130+

235+

30+

250+

Our Services

M&A/Divestiture

Funding/Investment

Partnership/Co-development

Licensing/Commercialization

Success Stories

Help us understand your needs

Latest News

New Client Win: Aagami Appointed to Secure Strategic Partnerships, Licensing, and Funding for Phase 3-Ready Cardiovascular Asset Targeting Atrial Fibrillation

New Client Win: Aagami Appointed by Innovative Biopharmaceutical Company to Secure Strategic Partnering and Global Licensing for Advanced Oncology and Rare Disease Pipelines

Aagami Appointed to Secure Exclusive Regional Partners in Japan and South Korea for Advanced Neurosurgical MRI and Robotics

Testimonials

“ We are pleased by Aagami Team’s good work, in a professional and gracious manner. We would be delighted to recommend your services to others ”

“ The virtues of working with Aagami include the team’s attentiveness to us and to the potential partners, persistence in follow-up and most of all, integrity”

“ We have worked with many Consultants in US and Canada, however, in our experience, none of them are worthy of even standing in Aagami’s Shadow. We are blessed to have Aagami on our side. ”

The service provided was excellent. Everything was handled in a thorough & professional manner. A large number of opportunities were identified, facilitated and progressed to a conclusion.

Aagami Team are Very Professional and Prompt in communication

Aagami laid out a pretty clear process and stuck to it, which is not often the case when engaging advisors for BD assignments. Also Aagami were very well connected. We had the opportunity to sign two deals via Aagami, which we had not anticipated.

Honest and transparent communication. Dedicated approach, hard working

"We were very satisfied with the outcome, and the final report, along with much additional data from subsequent trials conducted by our current licensees, now forms a part of our extensive Drug Master File at the FDA."

"Professional and disciplined approach to execution of the project."

Business Development support in regions
where you are unable to reach out due to bandwidth

Market Intelligence and IP Research
using new age tools

Deep Experience of overcoming
business and socio-cultural differences among various countries/regions